Home › Asset managers › Compare 2025-2026 › Equitable vs ProShares
Equitable 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,808 | 21,431 | 792 | 4,585 | 96.4% | 90.4% |
| Board proposals | 24,710 | 19,816 | 754 | 4,140 | 96.3% | 90.4% |
| E&S shareholder proposals | 172 | 83 | 0 | 89 | 100.0% | 86.7% |
| Other items | 1,926 | 1,532 | 38 | 356 | 97.6% | 90.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,140 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | ProShares |
|---|---|---|---|---|---|---|
| CLARITEV CORPORATION | April 29, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 5 funds |
| CLARITEV CORPORATION | April 29, 2026 | Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. Compensation |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 5 funds |
| CLARUS CORPORATION | May 28, 2026 | To approve an advisory resolution on executive compensation; Say-on-Pay |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 9 funds |
| CLEARPOINT NEURO, INC. | May 20, 2026 | An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST |
FOR 9 funds |
| CLEARPOINT NEURO, INC. | May 20, 2026 | Approval of ClearPoint Neuro, Inc.'s Seventh Amended and Restated 2013 Incentive Compensation Plan. Compensation |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 9 funds |
| CLEVELAND-CLIFFS INC. | May 14, 2026 | Approval, on an advisory basis, of Cleveland-Cliffs Inc.'s named executive officers' compensation. Say-on-Pay |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 7 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to implement a stock split in which (i) each share of Class A common stock would become one share of Class A common stock and one share of Class C common stock; and (ii) each share of Class B common stock would become one share of Class B common stock and one share of Class C common stock. Capital Structure |
Board | For | Split 3 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to increase the number of authorized shares of Class A common stock from 2,250,000,000 to 4,500,000,000. Capital Structure |
Board | For | Split 3 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up. Capital Structure |
Board | For | Split 3 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of an amendment and restatement of our amended and restated certificate of incorporation. Approval and adoption of amendments to establish the Class C common stock. Capital Structure |
Board | For | Split 1 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan. Compensation |
Board | For | Split 1 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan. Compensation |
Board | For | Split 3 FOR, 6 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 3 FOR, 6 AGAINST |
AGAINST 4 funds |
| CME GROUP INC | June 9, 2026 | Advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 19 funds |
| CME GROUP INC. | June 9, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 19 funds |
| CMS ENERGY CORPORATION | May 8, 2026 | Approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 18 funds |
| CNH INDUSTRIAL N V | May 8, 2026 | Approval of executive compensation ("say-on-pay") (advisory vote) Say-on-Pay |
Board | For | Split 5 FOR, 4 AGAINST |
FOR 8 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To hold an advisory vote to approve named executive officer compensation. Compensation |
Board | For | Split 3 FOR, 3 AGAINST |
AGAINST 14 funds |
| COGNEX CORPORATION | April 29, 2026 | Nominees: Nominated for a term ending in 2029: Angelos Papadimitriou Director Elections |
Board | For | Split 3 FOR, 5 AGAINST |
FOR 12 funds |
| COGNIZANT TECHNOLOGY SOLUTIONS CORP. | June 2, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers (say-on-pay). Say-on-Pay |
Board | For | Split 20 FOR, 1 AGAINST |
FOR 26 funds |
| COGNIZANT TECHNOLOGY SOLUTIONS CORP. | June 2, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 26 funds |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | Split 5 FOR, 1 AGAINST |
AGAINST 10 funds |
| COLGATE-PALMOLIVE COMPANY | May 8, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | Split 20 FOR, 1 AGAINST |
FOR 21 funds |
| COLGATE-PALMOLIVE COMPANY | May 8, 2026 | Ratify selection of PricewaterhouseCoopers LLP as Colgate's independent registered public accounting firm. Audit-related |
Board | For | Split 20 FOR, 1 AGAINST |
FOR 21 funds |
| COLOPLAST A/S | December 4, 2025 | AMEND REMUNERATION POLICY Say-on-Pay |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT ANNETTE BRULS AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT CARSTEN HELLMANN AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT JETTE NYGAARD-ANDERSEN AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT MARIANNE WIINHOLT AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 2 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT NIELS PETER LOUIS-HANSEN AS DIRECTOR Director Elections |
Board | For | Split 4 FOR, 3 ABSTAIN |
ABSTAIN 2 funds |
| COLUMBIA SPORTSWEAR COMPANY | June 10, 2026 | To approve the Columbia Sportswear Company Amended and Restated 2020 Stock Incentive Plan. Compensation |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 7 funds |
| COMCAST CORPORATION | June 10, 2026 | Advisory vote on executive compensation Say-on-Pay |
Board | For | Split 1 FOR, 16 AGAINST |
AGAINST 28 funds |
| COMERICA INCORPORATED | January 6, 2026 | Proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Comerica's named executive officers in connection with the first merger. Say-on-Pay |
Board | For | Split 8 FOR, 1 AGAINST |
AGAINST 10 funds |
| COMMSCOPE HOLDING COMPANY, INC. | October 16, 2025 | A proposal to adopt the Purchase Agreement and approve the transactions contemplated thereby, including the CCS Sale Transaction (the ''CCS Sale Proposal''). Extraordinary Transactions |
Board | For | Split 5 FOR, 3 ABSTAIN |
FOR 9 funds |
| COMPASS MINERALS INTERNATIONAL, INC. | March 5, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 9 funds |
| COMPOSECURE, INC. | December 23, 2025 | To approve the issuance of CompoSecure's Class A Common Stock, par value $0.0001 per share, in connection with the transactions contemplated by, and pursuant to the terms of, the Share Purchase Agreement (as it may be amended from time to time, the ''Transaction Agreement'') that we and certain of our subsidiaries entered into on November 2, 2025 with Husky Technologies Limited (''Husky''), Platinum Equity Advisors, LLC (''Platinum''), certain entitles affiliated with Platinum and certain members of Husky management, and the Purchase Agreements we entered into with certain institutional and other investors in connection with such transactions (the ''Stock Issuance Proposal''). Extraordinary Transactions |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Gina A. Norris Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Loretta J. Feehan Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
WITHHOLD 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Mary A. Tidlund Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Michael S. Simmons Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
WITHHOLD 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Scott C. James Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
WITHHOLD 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Terri L. Herrington Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Election of Directors: Thomas E. Barry Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 9 funds |
| COMPX INTERNATIONAL INC. | May 20, 2026 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 9 funds |
| CONCENTRIX CORPORATION | March 25, 2026 | Approval of an amendment to the Company's 2020 Stock Incentive Plan to increase the number of shares available for issuance. Compensation |
Board | For | Split 2 FOR, 4 AGAINST |
AGAINST 7 funds |
| CONFLUENT, INC. | February 12, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | Split 2 FOR, 4 AGAINST |
FOR 5 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: Deirdre Stanley Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: John F. Killian Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: Karol V. Mason Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: Linda S. Sanford Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: Michael W. Ranger Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Election of Directors: Timothy P. Cawley Director Elections |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED EDISON, INC. | May 18, 2026 | Ratification of appointment of independent accountants. Audit-related |
Board | For | Split 18 FOR, 1 AGAINST |
FOR 22 funds |
| CONSOLIDATED WATER CO. LTD. | June 1, 2026 | The approval of an Ordinary Resolution, attached as Exhibit A to the Proxy Statement, authorizing an increase of the share capital of the Company from (i) CI$12.5 million divided into 24,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50 each to (ii) CI$25 million divided into 49,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50. Capital Structure |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 10 funds |
| CONSTELLATION BRANDS, INC. | July 15, 2025 | To approve, by an advisory vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 17 funds |
| CONSTELLIUM SE | May 21, 2026 | Re-appointment of Mr. John Ormerod as a director for a term of three years Director Elections |
Board | For | Split 4 FOR, 2 AGAINST |
FOR 9 funds |
| CONSUMER PORTFOLIO SERVICES, INC. | November 19, 2025 | To approve the Company's 2025 Equity Incentive Plan. Compensation |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 9 funds |
| CONTANGO ORE, INC. | March 17, 2026 | The Share Increase Proposal - To approve the increase of the number of authorized Contango Shares from 45,000,000 shares to 250,000,000 shares and the related amendment to the Certificate of Incorporation of Contango, as amended (the "Charter") that will be set forth in a Certificate of Amendment to the Charter. Capital Structure |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 9 funds |
| CONTANGO SILVER & GOLD INC. | June 18, 2026 | Election of Directors: Brad Juneau Director Elections |
Board | For | Split 1 FOR, 4 WITHHOLD |
WITHHOLD 9 funds |
| CONTANGO SILVER & GOLD INC. | June 18, 2026 | Election of Directors: Michael Cinnamond Director Elections |
Board | For | Split 4 FOR, 1 WITHHOLD |
FOR 9 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Confirmation of the Remuneration of Directors and Remuneration Plan Compensation |
Board | For | Split 1 FOR, 1 AGAINST |
FOR 1 fund |
| COOPER COMPANIES INC | April 7, 2026 | Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | Split 18 FOR, 2 AGAINST |
FOR 17 funds |
| COPART, INC. | December 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2025. Say-on-Pay |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 29 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. Compensation |
Board | For | Split 1 FOR, 3 AGAINST |
AGAINST 5 funds |
| CORE LABORATORIES INC. | May 12, 2026 | To re-elect two current Class I Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2029 and until their successors shall have been duly elected and qualified; Harvey Klingensmith Director Elections |
Board | For | Split 3 FOR, 1 WITHHOLD |
FOR 13 funds |
| CORE MOLDING TECHNOLOGIES, INC. | May 14, 2026 | To approve an amendment to the Core Molding Technologies, Inc. 2021 Long-Term Equity Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 9 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 3 AGAINST |
AGAINST 10 funds |
| CORPAY, INC. | May 7, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 2 FOR, 16 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Annabelle Bexiga Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Hala G. Moddelmog Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Joseph W. Farrelly Director Elections |
Board | For | Split 1 FOR, 16 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Steven T. Stull Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Thomas M. Hagerty Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
AGAINST 17 funds |
| CORTEVA INC. | April 28, 2026 | Advisory resolution to approve executive compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 22 FOR, 1 AGAINST |
FOR 20 funds |
| CORVEL CORPORATION | August 7, 2025 | To approve the 2025 Stock Incentive Plan. Compensation |
Board | For | Split 3 FOR, 3 AGAINST |
AGAINST 11 funds |
| COSTAR GROUP, INC. | June 23, 2026 | Proposal to approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 20 FOR, 1 AGAINST |
FOR 25 funds |
| COSTCO WHOLESALE CORPORATION | January 15, 2026 | Ratification of selection of independent auditors. Audit-related |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 28 funds |
| COTERRA ENERGY INC. | May 4, 2026 | To adopt and approve the Agreement and Plan of Merger, dated as of February 1, 2026 (as amended from time to time, the ''Merger Agreement''), by and among Coterra Energy Inc. (''Coterra''), Devon Energy Corporation (''Devon'') and Cubs Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Devon (''Merger Sub''), the merger of Merger Sub into Coterra (the ''merger'') and the other transactions contemplated by the Merger Agreement (the ''Coterra Merger Proposal''); Extraordinary Transactions |
Board | For | Split 11 FOR, 8 ABSTAIN |
FOR 19 funds |
| COTERRA ENERGY INC. | May 4, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Coterra's named executive officers that is based on or otherwise relates to the merger (the ''Advisory Compensation Proposal''); and Say-on-Pay |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 19 funds |
| COUCHBASE, INC. | September 9, 2025 | To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated as of June 20, 2025, by and among Cascade Parent Inc., Cascade Merger Sub Inc., and Couchbase, Inc. (the "merger agreement"). Extraordinary Transactions |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 11 funds |
| CRA International, Inc. | July 17, 2025 | To consider and vote upon the election of two Class III Directors: Paul Maleh Director Elections |
Board | For | Split 5 FOR, 1 WITHHOLD |
FOR 8 funds |
| CRA International, Inc. | July 17, 2025 | To consider and vote upon the election of two Class III Directors: Thomas Avery Director Elections |
Board | For | Split 5 FOR, 1 WITHHOLD |
FOR 8 funds |
| CRESCENT ENERGY COMPANY | December 12, 2025 | To approve the issuance of shares of Class A common stock, par value $0.0001 per share, of Crescent Energy Company ("Crescent") in connection with the transactions contemplated by that certain Agreement and Plan of Merger, dated August 24, 2025, by and among Crescent, Vital Energy, Inc., Venus Merger Sub I Inc. and Venus Merger Sub II LLC (the "Crescent Issuance Proposal"). Extraordinary Transactions |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 12 funds |
| CREXENDO INC | December 2, 2025 | To consider and vote upon a proposal for advisory approval of the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST |
AGAINST 9 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | Split 5 FOR, 2 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. Compensation |
Board | For | Split 5 FOR, 2 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the 2025 Compensation Report. Say-on-Pay |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Briggs W. Morrison, M.D. Director Elections |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Christian Rommel, Ph.D. Director Elections |
Board | For | Split 6 FOR, 2 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Douglas A. Treco, Ph.D. Director Elections |
Board | For | Split 2 FOR, 5 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of John T. Greene Director Elections |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Katherine A. High, M.D. Director Elections |
Board | For | Split 6 FOR, 2 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Maria Fardis, Ph.D. Director Elections |
Board | For | Split 6 FOR, 2 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Sandesh Mahatme, LL.M. Director Elections |
Board | For | Split 6 FOR, 2 AGAINST |
FOR 13 funds |
← Previous Page 8 of 42 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.